Table 6.
Association with Helicobacter pylori infection and gastrointestinal tract lymphoma
|
|
Prevalence of H. pylori
|
Diagnostic tool for H. pylori
|
Study design
|
P
value
|
| Parsonnet et al[95] (Gastric NHL) | OR: 6.3; 95%CI: 2.0-19.9 | Serology | Case- control study | NA |
| Ishikura et al[97] (Gastric lymphoma overall) | OR: 2.14; 95%CI: 1.3-3.5 | Serology | Case- control study | P = 0.003 |
| Ishikura et al[97] (Gastric MALT) | OR: 1.96; 95%CI: 1.0-3.9 | Serology | Case- control study | P = 0.051 |
| Ishikura et al[97] (Gastric DLBCL) | OR: 1.92; 95%CI: 0.74-4.95 | Serology | Case- control study | P = 0.178 |
| Parsonnet et al[95] (Non-gastric NHL) | OR: 1.2; 95%CI: 0.5-3.0 | Serology | Case- control study | NA |
NHL: Non-Hodgkin’s lymphomas; MALT: Mucosa-associated lymphoid tissue; DLBCL: Diffuse large B-cell lymphoma; OR: Odds ratio; CI: Confidence interval; H. pylori: Helicobacter pylori; NA: Not available.